# MTURN

## Overview
MTURN is a gene that encodes the protein maturin, which functions as a neural progenitor differentiation regulator. Maturin is primarily involved in the differentiation and maturation of neural progenitor cells into specialized neurons, playing a crucial role in neurogenesis and brain development. The protein is active in the nucleus, where it influences transcriptional processes essential for the proper development and functionality of neural networks. Although the specific molecular mechanisms of MTURN in healthy human cells are not fully detailed, its role in neural differentiation suggests interactions with various transcription factors and signaling pathways. Additionally, alterations in MTURN expression have been linked to lung cancer, particularly in female patients, highlighting its potential as a diagnostic biomarker and its clinical significance in cancer detection and treatment response (Liu2019A).

## Function
MTURN, also known as maturin, is a gene involved in the differentiation of neural progenitor cells. It plays a critical role in the development and maturation of neural cells by regulating gene expression and cellular pathways essential for neurogenesis. MTURN is active in the nucleus, where it influences transcriptional processes that guide the maturation of neural progenitors into specialized neurons. This activity is crucial for proper brain development and function, as it ensures the correct differentiation and specialization of neural cells. The gene's involvement in these processes highlights its importance in maintaining the balance and functionality of neural networks in the brain. While the specific molecular mechanisms of MTURN in healthy human cells are not detailed in the provided context, its role in neural progenitor differentiation suggests it may interact with various transcription factors and signaling pathways to facilitate neurogenesis. The study by Liu et al. does not provide specific information on the function of MTURN in healthy human cells, focusing instead on its altered expression in the context of lung cancer (Liu2019A).

## Clinical Significance
Alterations in the expression of the MTURN gene have been associated with lung cancer, particularly in female patients. The MTURN mRNA shows higher expression levels in female lung cancer patients compared to healthy female donors, indicating its potential as a diagnostic biomarker for this subgroup (Liu2019A). The study by Liu et al. demonstrated that MTURN, along with MAX and HLA-B, forms a three-platelet mRNA set that is significantly up-regulated in lung cancer patients. This set has been proposed as a non-invasive blood-based test for lung cancer detection and therapy response prediction (Liu2019A).

The expression of MTURN mRNA is also linked to chemotherapy response. Lower expression levels of MTURN, MAX, and HLA-B mRNA correlate with a favorable response to first-line chemotherapy, suggesting that MTURN may serve as a biomarker for predicting chemotherapeutic effects (Liu2019A). Post-operative analysis revealed that MTURN expression decreases significantly after surgery, which suggests a correlation with tumor presence (Liu2019A). These findings highlight the clinical significance of MTURN in lung cancer diagnosis and treatment monitoring.


## References


[1. (Liu2019A) Lele Liu, Xingguo Song, Xinyi Li, Linlin Xue, Shanshan Ding, Limin Niu, Li Xie, and Xianrang Song. A three-platelet mrna set: max, mturn and hla-b as biomarker for lung cancer. Journal of Cancer Research and Clinical Oncology, 145(11):2713â€“2723, September 2019. URL: http://dx.doi.org/10.1007/s00432-019-03032-9, doi:10.1007/s00432-019-03032-9. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00432-019-03032-9)